Logo image of BDR

Blonder Tongue Laboratories Inc (BDR) Stock Earnings & Estimates

NYSEARCA:BDR - US0936981085 - Common Stock

0.305
+0 (+1.46%)
Last: 6/24/2022, 8:26:09 PM
0.305
0 (0%)
After Hours: 6/24/2022, 8:26:09 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021
Revenue
YoY % growth
BDR revenue by date.BDR revenue by date.
19.84M
-8.61%
16.38M
-17.44%
15.75M
-3.85%
EBITDA
YoY % growth
BDR ebitda by date.BDR ebitda by date.
-7.25M
-2,096.97%
-6.76M
6.76%
-2.62M
61.24%
EBIT
YoY % growth
BDR ebit by date.BDR ebit by date.
-7.64M
-798.82%
-7.11M
6.94%
-2.96M
58.37%
Operating Margin
BDR operating margin by date.BDR operating margin by date.
-38.51%-43.41%-18.79%
EPS
YoY % growth
BDR eps by date.BDR eps by date.
N/AN/AN/A

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

Recent Earnings VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises

Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .

PeriodReportedEstimateDifferenceSurprise
Q1 2022
Q2Q % growth
3.34M
2.74%
%
Q4 2021
Q2Q % growth
3.99M
-7.79%
%
Q3 2021
Q2Q % growth
4.17M
-0.02%
%
Q2 2021
Q2Q % growth
4.34M
13.29%
%
Q1 2021
Q2Q % growth
3.251M
-19.73%
%
Q4 2020
Q2Q % growth
4.327M
-14.23%
%
Q3 2020
Q2Q % growth
4.171M
-20.97%
%
Q2 2020
Q2Q % growth
3.831M
-29.54%
%
Q1 2020
Q2Q % growth
4.05M
-0.78%
%
BDR Yearly Revenue VS EstimatesBDR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A